Oramed Pharmaceuticals Inc. is a pioneering biopharmaceutical company headquartered in New York, specializing in innovative oral drug delivery systems aimed at revolutionizing diabetes management. The company is developing unique orally ingestible capsules designed for the administration of polypeptides, thereby improving patient adherence and overall health outcomes. With a promising pipeline of therapeutic solutions targeted at critical unmet medical needs, Oramed is well-positioned to become a leader in the diabetes treatment landscape, significantly enhancing the quality of life for patients globally. Show more

Location: 1185 AVENUE OF THE AMERICAS, NEW YORK, NY, UNITED STATES, 10036, New York, NY, 10036, USA | Website: https://www.oramed.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

134.3M

52 Wk Range

$1.70 - $3.71

Previous Close

$3.42

Open

$3.40

Volume

140,492

Day Range

$3.29 - $3.42

Enterprise Value

2.297M

Cash

52.18M

Avg Qtr Burn

-1.987M

Insider Ownership

14.63%

Institutional Own.

23.21%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
ORMD-0801 (ORA-D-013-1) Details Diabetes, Type 2 diabetes	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ORMD-0801 Details Non-alcoholic steatohepatitis , Liver disease	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.